These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 2040714

  • 1. Acute noradrenergic effects of desipramine in depression.
    Rudorfer MV, Sherer MA, Lane EA, Golden RN, Linnoila M, Potter WZ.
    J Clin Psychopharmacol; 1991 Feb; 11(1):22-7. PubMed ID: 2040714
    [Abstract] [Full Text] [Related]

  • 2. Effects of chronic desipramine on plasma norepinephrine concentrations and cardiovascular parameters in elderly depressed women: a preliminary report.
    Cutler NR, Zavadil AP, Linnoila M, Scheinin M, Rudorfer MV, Potter WZ.
    Biol Psychiatry; 1984 Apr; 19(4):549-56. PubMed ID: 6733174
    [Abstract] [Full Text] [Related]

  • 3. Exaggerated orthostatic responsivity of plasma norepinephrine in depression.
    Rudorfer MV, Ross RJ, Linnoila M, Sherer MA, Potter WZ.
    Arch Gen Psychiatry; 1985 Dec; 42(12):1186-92. PubMed ID: 3000316
    [Abstract] [Full Text] [Related]

  • 4. Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics.
    Veith RC, Lewis N, Linares OA, Barnes RF, Raskind MA, Villacres EC, Murburg MM, Ashleigh EA, Castillo S, Peskind ER.
    Arch Gen Psychiatry; 1994 May; 51(5):411-22. PubMed ID: 8179465
    [Abstract] [Full Text] [Related]

  • 5. ECG effects of comparable plasma concentrations of desipramine and amitriptyline.
    Veith RC, Bloom V, Bielski R, Friedel RO.
    J Clin Psychopharmacol; 1982 Dec; 2(6):394-8. PubMed ID: 7174862
    [Abstract] [Full Text] [Related]

  • 6. Fenfluramine augmentation in tricyclic-refractory depression.
    Price LH, Charney DS, Delgado PL, Heninger GR.
    J Clin Psychopharmacol; 1990 Oct; 10(5):312-7. PubMed ID: 2258448
    [Abstract] [Full Text] [Related]

  • 7. Diurnal neuroendocrine and autonomic function in acute and remitted depressed male patients.
    Trestman RL, Yehuda R, Coccaro E, Horvath T, Knott P, Gabriel S, Siever LJ.
    Biol Psychiatry; 1995 Apr 01; 37(7):448-56. PubMed ID: 7786958
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients.
    Fawcett J, Edwards JH, Kravitz HM, Jeffriess H.
    J Clin Psychopharmacol; 1987 Oct 01; 7(5):295-310. PubMed ID: 3316312
    [Abstract] [Full Text] [Related]

  • 10. Desipramine plasma levels and response in elderly melancholic patients.
    Nelson JC, Jatlow PI, Mazure C.
    J Clin Psychopharmacol; 1985 Aug 01; 5(4):217-20. PubMed ID: 4019810
    [Abstract] [Full Text] [Related]

  • 11. Possible nonlinear pharmacokinetics of desipramine after once daily dosing.
    Amsterdam JD, Brunswick DJ, Potter L, Rickels K.
    Pharmacopsychiatry; 1986 Mar 01; 19(2):84-7. PubMed ID: 3703927
    [Abstract] [Full Text] [Related]

  • 12. Estimating steady state desipramine levels in noninstitutionalized elderly patients using single dose disposition parameters.
    Antal EJ, Lawson IR, Alderson LM, Chapron DJ, Kramer PA.
    J Clin Psychopharmacol; 1982 Jun 01; 2(3):193-8. PubMed ID: 7096608
    [Abstract] [Full Text] [Related]

  • 13. [Pharmacological treatment of delusional depression].
    Amore M, Giordani L, Giorgetti G, Zazzeri N.
    Minerva Psichiatr; 1996 Mar 01; 37(1):29-33. PubMed ID: 8804200
    [Abstract] [Full Text] [Related]

  • 14. Norepinephrine precursor therapy in neurogenic orthostatic hypotension.
    Kaufmann H, Saadia D, Voustianiouk A, Goldstein DS, Holmes C, Yahr MD, Nardin R, Freeman R.
    Circulation; 2003 Aug 12; 108(6):724-8. PubMed ID: 12885750
    [Abstract] [Full Text] [Related]

  • 15. Effects of electroconvulsive therapy and desipramine on neuroendocrine responses to the clonidine challenge test.
    Coote M, Wilkins A, Werstiuk ES, Steiner M.
    J Psychiatry Neurosci; 1998 May 12; 23(3):172-8. PubMed ID: 9595891
    [Abstract] [Full Text] [Related]

  • 16. Acute cardiovascular effects of tranylcypromine: correlation with plasma drug, metabolite, norepinephrine, and MHPG levels.
    Keck PE, Carter WP, Nierenberg AA, Cooper TB, Potter WZ, Rothschild AJ.
    J Clin Psychiatry; 1991 Jun 12; 52(6):250-4. PubMed ID: 2055897
    [Abstract] [Full Text] [Related]

  • 17. Impairment of endothelial function in unipolar and bipolar depression.
    Rybakowski JK, Wykretowicz A, Heymann-Szlachcinska A, Wysocki H.
    Biol Psychiatry; 2006 Oct 15; 60(8):889-91. PubMed ID: 16730331
    [Abstract] [Full Text] [Related]

  • 18. The effect of clorgyline on noradrenergic function.
    Ross RJ, Scheinin M, Lesieur P, Rudorfer MV, Hauger RL, Siever LJ, Linnoila M, Potter WZ.
    Psychopharmacology (Berl); 1985 Oct 15; 85(2):227-30. PubMed ID: 3925487
    [Abstract] [Full Text] [Related]

  • 19. Yohimbine effects on blood pressure and plasma catecholamines in human hypertension.
    Musso NR, Vergassola C, Pende A, Lotti G.
    Am J Hypertens; 1995 Jun 15; 8(6):565-71. PubMed ID: 7662240
    [Abstract] [Full Text] [Related]

  • 20. New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha 2-adrenergic agonist clonidine.
    Siever LJ, Uhde TW.
    Biol Psychiatry; 1984 Feb 15; 19(2):131-56. PubMed ID: 6324896
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.